{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:25:31Z","timestamp":1792121131998,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"micinn","doi-asserted-by":"crossref","award":["RTI2018-101269-B-I00"],"award-info":[{"award-number":["RTI2018-101269-B-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic syndrome (MetS) is a multimorbid long-term condition without consensual medical definition and a diagnostic based on compatible symptomatology. Here we have investigated the molecular signature of MetS in urine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used NMR-based metabolomics to investigate a European cohort including urine samples from 11,754 individuals (18\u201375\u00a0years old, 41% females), designed to populate all the intermediate conditions in MetS, from subjects without any risk factor up to individuals with developed MetS (4\u20135%, depending on the definition). A set of quantified metabolites were integrated from the urine spectra to obtain metabolic models (one for each definition), to discriminate between individuals with MetS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      MetS progression produces a continuous and monotonic variation of the urine metabolome, characterized by up- or down-regulation of the pertinent metabolites (17 in total, including glucose, lipids, aromatic amino acids, salicyluric acid, maltitol, trimethylamine\n                      <jats:italic>N<\/jats:italic>\n                      -oxide, and\n                      <jats:italic>p<\/jats:italic>\n                      -cresol sulfate) with some of the metabolites associated to MetS for the first time. This metabolic signature, based solely on information extracted from the urine spectrum, adds a molecular dimension to MetS definition and it was used to generate models that can identify subjects with MetS (AUROC values between 0.83 and 0.87). This signature is particularly suitable to add meaning to the conditions that are in the interface between healthy subjects and MetS patients. Aging and non-alcoholic fatty liver disease are also risk factors that may enhance MetS probability, but they do not directly interfere with the metabolic discrimination of the syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Urine metabolomics, studied by NMR spectroscopy, unravelled a set of metabolites that concomitantly evolve with MetS progression, that were used to derive and validate a molecular definition of MetS and to discriminate the conditions that are in the interface between healthy individuals and the metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-021-01349-9","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T10:02:46Z","timestamp":1627466566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["A molecular signature for the metabolic syndrome by urine metabolomics"],"prefix":"10.1186","volume":"20","author":[{"given":"Chiara","family":"Bruzzone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Gil-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Seco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Cannet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammo","family":"Diercks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maider","family":"Bizkarguenaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gonz\u00e1lez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"La\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantza","family":"Sanz-Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Coltell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander L\u00f3pez","family":"de Letona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Spraul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly C.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Buguianesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Embade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin M.","family":"Anstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Corella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8748-4105","authenticated-orcid":false,"given":"Oscar","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"1349_CR1","doi-asserted-by":"publisher","unstructured":"Day C. Metabolic syndrome, or What you will: Definitions and epidemiology. In: Diabetes and Vascular Disease Research. Vol. 4. London: SAGE PublicationsSage; 2007, 32\u20138. https:\/\/doi.org\/10.3132\/dvdr.2007.003","DOI":"10.3132\/dvdr.2007.003"},{"key":"1349_CR2","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/978-3-030-36694-0","volume-title":"Diabetes complications, comorbidities and related disorders","author":"E Bonora","year":"2020","unstructured":"Bonora E, DeFronzo RA. Diabetes complications, comorbidities and related disorders. Berlin: Springer; 2020. p. 451\u201371."},{"issue":"2_suppl","key":"1349_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/2047487319886404","volume":"26","author":"PM Nilsson","year":"2019","unstructured":"Nilsson PM, Tuomilehto J, Ryd\u00e9n L. The metabolic syndrome\u2013what is it and how should it be managed? Eur J Prev Cardiol. 2019;26(2_suppl):33\u201346.","journal-title":"Eur J Prev Cardiol."},{"issue":"4","key":"1349_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1161\/ATVBAHA.107.151092","volume":"28","author":"SM Grundy","year":"2008","unstructured":"Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629\u201336.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1349_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/eurheartj\/sui021","volume":"7","author":"G Alberti","year":"2005","unstructured":"Alberti G. Introduction to the metabolic syndrome. Eur Hear Journal. 2005;7:3\u20135.","journal-title":"Eur Hear Journal."},{"issue":"16","key":"1349_CR6","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation. Int Circ. 2009;120(16):1640\u20135.","journal-title":"Int Circ"},{"issue":"9491","key":"1349_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KGMM Alberti","year":"2005","unstructured":"Alberti KGMM, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366(9491):1059\u201362.","journal-title":"Lancet"},{"issue":"3","key":"1349_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.metabol.2007.10.010","volume":"57","author":"P Strazzullo","year":"2008","unstructured":"Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiattarella P, et al. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population. Metabolism. 2008;57(3):355\u201361.","journal-title":"Metabolism"},{"issue":"9501","key":"1349_CR9","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)67780-X","volume":"366","author":"HK Neuhauser","year":"2005","unstructured":"Neuhauser HK. The metabolic syndrome. Lancet. 2005;366(9501):1415\u201328.","journal-title":"Lancet"},{"issue":"2","key":"1349_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1751-2980.2011.00487.x","volume":"12","author":"SH Chen","year":"2011","unstructured":"Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011;12(2):125\u201330. https:\/\/doi.org\/10.1111\/j.1751-2980.2011.00487.x.","journal-title":"J Dig Dis"},{"issue":"1","key":"1349_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56909-7","volume":"10","author":"S Monnerie","year":"2020","unstructured":"Monnerie S, Comte B, Ziegler D, Morais JA, Pujos-Guillot E, Gaudreau P. Metabolomic and lipidomic signatures of metabolic syndrome and its physiological components in adults: a systematic review. Sci Rep. 2020;10(1):1\u201313.","journal-title":"Sci Rep"},{"issue":"1","key":"1349_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12940-016-0136-x","volume":"15","author":"TM James-Todd","year":"2016","unstructured":"James-Todd TM, Huang T, Seely EW, Saxena AR. The association between phthalates and metabolic syndrome: the National Health and Nutrition Examination Survey 2001\u20132010. Environ Health. 2016;15(1):52. https:\/\/doi.org\/10.1186\/s12940-016-0136-x.","journal-title":"Environ Health"},{"issue":"8","key":"1349_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jdiacomp.2018.05.014","volume":"32","author":"N Ramakrishanan","year":"2018","unstructured":"Ramakrishanan N, Denna T, Devaraj S, Adams-Huet B, Jialal I. Exploratory lipidomics in patients with nascent metabolic syndrome. J Diabetes Complicat. 2018;32(8):791\u20134.","journal-title":"J Diabetes Complicat"},{"issue":"3","key":"1349_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jdiacomp.2018.12.002","volume":"33","author":"K Shim","year":"2019","unstructured":"Shim K, Gulhar R, Jialal I. Exploratory metabolomics of nascent metabolic syndrome. J Diabetes Complicat. 2019;33(3):212\u20136.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"1349_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4239\/wjd.v10.i1.23","volume":"10","author":"D Lent-Schochet","year":"2019","unstructured":"Lent-Schochet D, McLaughlin M, Ramakrishnan N, Jialal I. Exploratory metabolomics of metabolic syndrome: a status report. World J Diabetes. 2019;10(1):23\u201336.","journal-title":"World J Diabetes"},{"issue":"3\u20134","key":"1349_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10858-011-9489-1","volume":"49","author":"P Bernini","year":"2011","unstructured":"Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P. Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR. 2011;49(3\u20134):231\u201343.","journal-title":"J Biomol NMR"},{"issue":"1","key":"1349_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1758-5996-6-40","volume":"6","author":"PK Wiklund","year":"2014","unstructured":"Wiklund PK, Pekkala S, Autio R, Munukka E, Xu L, Saltevo J, et al. Serum metabolic profiles in overweight and obese women with and without metabolic syndrome. Diabetol Metab Syndr. 2014;6(1):40. https:\/\/doi.org\/10.1186\/1758-5996-6-40.","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"1349_CR18","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1021\/acs.jproteome.0c00091","volume":"19","author":"C Bruzzone","year":"2020","unstructured":"Bruzzone C, Loizaga-Iriarte A, Sanchez-Mosquera P, Gil-Redondo R, Astobiza I, Diercks T, et al. 1H-NMR-based urine metabolomics reveals signs of enhanced carbon and nitrogen recycling in prostate cancer. J Proteome Res. 2020;19(6):2419\u201328.","journal-title":"J Proteome Res"},{"issue":"10","key":"1349_CR19","doi-asserted-by":"publisher","first-page":"101645","DOI":"10.1016\/j.isci.2020.101645","volume":"23","author":"C Bruzzone","year":"2020","unstructured":"Bruzzone C, Bizkarguenaga M, Gil-Redondo R, Diercks T, Arana E, Garc\u00eda de Vicu\u00f1a A, et al. SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum. iScience. 2020;23(10):101645.","journal-title":"iScience."},{"issue":"9","key":"1349_CR20","doi-asserted-by":"publisher","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","volume":"8","author":"S Bouatra","year":"2013","unstructured":"Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, et al. The human urine metabolome. PLoS ONE. 2013;8(9):e73076.","journal-title":"PLoS ONE."},{"issue":"5","key":"1349_CR21","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","volume":"62","author":"S McPherson","year":"2015","unstructured":"McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. J Hepatol. 2015;62(5):1148\u201355.","journal-title":"J Hepatol"},{"issue":"5","key":"1349_CR22","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/hep.27999","volume":"62","author":"S Singh","year":"2015","unstructured":"Singh S, Khera R, Allen AM, Murad MH, Loomba R. Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: a systematic review and network meta-analysis. Hepatology. 2015;62(5):1417\u201332.","journal-title":"Hepatology"},{"key":"1349_CR23","unstructured":"The Handbook of Metabonomics and Metabolomics - 1st Edition. https:\/\/www.elsevier.com\/books\/the-handbook-of-metabonomics-and-metabolomics\/lindon\/978-0-444-52841-4. Accessed 5 Apr 2021."},{"issue":"11","key":"1349_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.numecd.2017.07.006","volume":"27","author":"A Ntzouvani","year":"2017","unstructured":"Ntzouvani A, Nomikos T, Panagiotakos D, Fragopoulou E, Pitsavos C, McCann A, et al. Amino acid profile and metabolic syndrome in a male Mediterranean population: a cross-sectional study. Nutr Metab Cardiovasc Dis. 2017;27(11):1021\u201330.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"1349_CR25","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1007\/s00125-017-4325-0","volume":"60","author":"G Peddinti","year":"2017","unstructured":"Peddinti G, Cobb J, Yengo L, Froguel P, Kravi\u0107 J, Balkau B, et al. Early metabolic markers identify potential targets for the prevention of type 2 diabetes. Diabetologia. 2017;60(9):1740\u201350. https:\/\/doi.org\/10.1007\/s00125-017-4325-0.","journal-title":"Diabetologia"},{"issue":"5","key":"1349_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jdiacomp.2018.02.005","volume":"32","author":"P Reddy","year":"2018","unstructured":"Reddy P, Leong J, Jialal I. Amino acid levels in nascent metabolic syndrome: a contributor to the pro-inflammatory burden. J Diabetes Complicat. 2018;32(5):465\u20139.","journal-title":"J Diabetes Complicat"},{"issue":"1","key":"1349_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/obr.12229","volume":"16","author":"S O\u2019Neill","year":"2015","unstructured":"O\u2019Neill S, O\u2019Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1\u201312.","journal-title":"Obes Rev"},{"issue":"1","key":"1349_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1681\/ASN.2012050503","volume":"24","author":"L Koppe","year":"2013","unstructured":"Koppe L, Pillon NJ, Vella RE, Croze ML, Pelletier CC, Chambert S, et al. p-Cresyl sulfate promotes insulin resistance associated with CKD. J Am Soc Nephrol. 2013;24(1):88\u201399.","journal-title":"J Am Soc Nephrol"},{"key":"1349_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1749-6632.1995.tb32460.x","volume":"763","author":"SG Sch\u00e4fer","year":"1995","unstructured":"Sch\u00e4fer SG, Kaan EC, Christen MO, L\u00f6w-Kr\u00f6ger A, Mest H-J, Molderings G-J. Why imidazoline receptor modulator in the treatment of hypertension? Ann N Y Acad Sci. 1995;763:659\u201372.","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"1349_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1124\/pr.118.016311","volume":"72","author":"P Bousquet","year":"2020","unstructured":"Bousquet P, Hudson A, Garc\u00eda-Sevilla JA, Li JX. Imidazoline receptor system: the past, the present, and the future. Pharmacol Rev. 2020;72(1):50\u201379.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"1349_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.5114\/aoms.2016.59925","volume":"12","author":"A Olszanecka","year":"2016","unstructured":"Olszanecka A, Kawecka-Jaszcz K, Czarnecka D. Association of free testosterone and sex hormone binding globulin with metabolic syndrome and subclinical atherosclerosis but not blood pressure in hypertensive perimenopausal women. Arch Med Sci. 2016;12(3):521\u20138.","journal-title":"Arch Med Sci"},{"issue":"3","key":"1349_CR32","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/nu12030806","volume":"12","author":"J Hernandez-Baixauli","year":"2020","unstructured":"Hernandez-Baixauli J, Quesada-V\u00e1zquez S, Marin\u00e9-Casad\u00f3 R, Gil Cardoso K, Caimari A, Del Bas JM, et al. Detection of early disease risk factors associated with metabolic syndrome: a new era with the NMR metabolomics assessment. Nutrients. 2020;12(3):806.","journal-title":"Nutrients."},{"issue":"8","key":"1349_CR33","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.metabol.2005.03.006","volume":"54","author":"K Blouin","year":"2005","unstructured":"Blouin K, Despr\u00e9s J-P, Couillard C, Tremblay A, Prud\u2019homme D, Bouchard C, et al. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism. 2005;54(8):1034\u201340.","journal-title":"Metabolism."},{"issue":"5","key":"1349_CR34","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1152\/ajpendo.00293.2017","volume":"314","author":"GB Marchand","year":"2018","unstructured":"Marchand GB, Carreau A-M, Weisnagel SJ, Bergeron J, Labrie F, Lemieux S, et al. Increased body fat mass explains the positive association between circulating estradiol and insulin resistance in postmenopausal women. Am J Physiol Metab. 2018;314(5):E448\u201356. https:\/\/doi.org\/10.1152\/ajpendo.00293.2017.","journal-title":"Am J Physiol Metab"},{"issue":"2","key":"1349_CR35","doi-asserted-by":"publisher","first-page":"e0148361","DOI":"10.1371\/journal.pone.0148361","volume":"11","author":"JE Ho","year":"2016","unstructured":"Ho JE, Larson MG, Ghorbani A, Cheng S, Chen M-H, Keyes M, et al. Metabolomic profiles of body mass index in the Framingham Heart Study reveal distinct cardiometabolic phenotypes. PLoS ONE. 2016;11(2):e0148361. https:\/\/doi.org\/10.1371\/journal.pone.0148361.","journal-title":"PLoS ONE."},{"issue":"5","key":"1349_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11051091","volume":"11","author":"G Vizzari","year":"2019","unstructured":"Vizzari G, Sommariva MC, Cas MD, Bertoli S, Vizzuso S, Radaelli G, et al. Circulating salicylic acid and metabolic profile after 1-year nutritional\u2013behavioral intervention in children with obesity. Nutrients. 2019;11(5):1\u201311.","journal-title":"Nutrients"},{"issue":"12","key":"1349_CR37","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3390\/nu10121971","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea L, Annunziata G, Muscogiuri G, Di Somma C, Laudisio D, Maisto M, et al. Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients. 2018;10(12):1971.","journal-title":"Nutrients"},{"key":"1349_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fendo.2019.00168\/full","volume":"10","author":"X Gao","year":"2019","unstructured":"Gao X, Tian Y, Randell E, Zhou H, Sun G. Unfavorable associations between serum trimethylamine N-Oxide and l-Carnitine levels with components of metabolic syndrome in the Newfoundland Population. Front Endocrinol. 2019;10:168. https:\/\/doi.org\/10.3389\/fendo.2019.00168\/full.","journal-title":"Front Endocrinol"},{"key":"1349_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-7-220","volume":"7","author":"B Hildrum","year":"2007","unstructured":"Hildrum B, Mykletun A, Hole T, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: The Norwegian HUNT 2 study. BMC Public Health. 2007;7:1\u20139.","journal-title":"BMC Public Health"},{"issue":"1","key":"1349_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-020-00634-0","volume":"20","author":"MM Saadi","year":"2020","unstructured":"Saadi MM, Roy MN, Haque R, Tania FA, Mahmood S, Ali N. Association of microalbuminuria with metabolic syndrome: a cross-sectional study in Bangladesh. BMC Endocr Disord. 2020;20(1):1\u20137.","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"1349_CR41","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604.","journal-title":"Ann Intern Med."},{"issue":"4","key":"1349_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","volume":"28","author":"P Dietrich","year":"2014","unstructured":"Dietrich P, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Pract Res Clin Gastroenterol. 2014;28(4):637\u201353.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1349_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2337\/diacare.25.1.148","volume":"25","author":"MJ Franz","year":"2002","unstructured":"Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care. 2002;25:148\u201398.","journal-title":"Diabetes Care."},{"issue":"1","key":"1349_CR44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1573402115666190415161813","volume":"16","author":"A Katsimardou","year":"2019","unstructured":"Katsimardou A, Imprialos K, Stavropoulos K, Sachinidis A, Doumas M, Athyros V. Hypertension in metabolic syndrome: novel insights. Curr Hypertens Rev. 2019;16(1):12\u20138.","journal-title":"Curr Hypertens Rev"},{"issue":"6","key":"1349_CR45","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1021\/acs.jproteome.7b00116","volume":"16","author":"E Pujos-Guillot","year":"2017","unstructured":"Pujos-Guillot E, Brandolini M, P\u00e9t\u00e9ra M, Grissa D, Joly C, Lyan B, et al. Systems metabolomics for prediction of metabolic syndrome. J Proteome Res. 2017;16(6):2262\u201372. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00116.","journal-title":"J Proteome Res"},{"issue":"1","key":"1349_CR46","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1741-7015-9-48","volume":"9","author":"E Kassi","year":"2011","unstructured":"Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9(1):48. https:\/\/doi.org\/10.1186\/1741-7015-9-48.","journal-title":"BMC Med"},{"issue":"12","key":"1349_CR47","first-page":"1","volume":"10","author":"L Barrea","year":"2018","unstructured":"Barrea L, Annunziata G, Muscogiuri G, Di Somma C, Laudisio D, Maisto M, et al. Trimethylamine-N-oxide (TMAO) as novel potential biomarker of early predictors of metabolic syndrome. Nutrients. 2018;10(12):1\u201319.","journal-title":"Nutrients"},{"issue":"10","key":"1349_CR48","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/oby.21199","volume":"23","author":"M Favennec","year":"2015","unstructured":"Favennec M, Hennart B, Caiazzo R, Leloire A, Yengo L, Verbanck M, et al. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Obesity. 2015;23(10):2066\u201374. https:\/\/doi.org\/10.1002\/oby.21199.","journal-title":"Obesity"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01349-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-021-01349-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-021-01349-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T22:02:40Z","timestamp":1627509760000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-021-01349-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1186\/s12933-021-01349-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-617098\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"13 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Following the Declaration of Helsinki principles, all participants in the study provided informed consent to clinical investigations, with evaluation and approval from the corresponding ethics committee (Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica de Euskadi PI2016114). All data was anonymized to protect the confidentiality of participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}